Phosphorylated α-synuclein (p-αS) can interact with cytoskeletal proteins to block vesicular transport, enhance the aggregation of α-synuclein in vivo and in vitro, induce the formation of toxic aggregates, and accelerate the progress of PD. This evidence concerns the gene SNCA and Parkinson disease.